Phase 1 Study Measuring Dosing Effects of LSD Completed: Results of Study Will Aid In Planning a Phase 2 Study
The study was conducted in partnership with University Hospital Basel’s Liechti Lab.
November 2, 2020
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
View the latest clinical trials, studies, data, and updates.
Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis: Case Report Published in the Journal of Vascular Surgery
Ellipsys System creates a type of dialysis access known as a percutaneous arteriovenous fistula (pAVF) for patients with end-stage renal disease (ESRD) who require hemodialysis.
October 30, 2020
Advanced Chemotherapy Technologies Achieves $5.5M Series A Financing: Company to Pursue First Clinical Trials of ACT-IOP-003 Targeting Advanced Pancreatic Cancer
The capital will be used to fund initial clinical development of the company’s ACT-IOP-003 local chemotherapy system for the treatment of locally advanced non-resectable and borderline resectable pancreatic cancer.
October 29, 2020
WATCHMAN FLX Left Atrial Appendage Closure Device Trial Initiated Reports Boston Scientific
The device will be compared to treatment with non-vitamin K antagonist oral anticoagulants (NOACs), considered the leading contemporary drugs for stroke risk reduction in this population.
October 29, 2020
Selective Cytopheretic Device Study in Pediatric Patients with Acute Kidney Injury Shows Positive Results
Selective Cytopheretic Device study’s primary objective was to assess the safety of the device in children. Safety was determined by adverse events related to treatment up to 60 days following treatment initiation.
October 26, 2020
DTM Spinal Cord Stimulation 12 Month Study Results Reported by Medtronic
At 12 months, 84% of patients with chronic back pain treated with DTM Spinal Cord Stimulation reported at least 50% pain relief, compared to 51% of patients treated with conventional SCS (p=0.0005).
October 20, 2020
